ClinicalTrials.Veeva

Menu

The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney Transplantation (RINNOR)

K

King Chulalongkorn Memorial Hospital

Status and phase

Active, not recruiting
Phase 3

Conditions

Kidney Transplant; Complications
Electrolyte Imbalance

Treatments

Drug: Ringer's Lactate Crystalloid Solutions
Drug: Normal saline

Study type

Interventional

Funder types

Other

Identifiers

NCT06030609
CUKT-FLUID

Details and patient eligibility

About

This is a randomized controlled pragmatic clinical trial. We aim to evaluate the effect of Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W) on the electrolyte abnormality of kidney transplant recipients (KTR) during the first post-operative week. The problem with using NSS with or without D5W as a standard replacement fluid is the hyperchloremic metabolic acidosis which might compromise the kidney allograft function. A total 60 KTR will be enrolled and randomized to receive either RLS or NSS with D5W. The primary outcome is serum bicarbonate level at day 5 after transplantation. Secondary outcomes include the serum potassium, serum sodium, serum chloride, cytokine panel, and the incidence of delayed graft function.

Enrollment

159 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A kidney transplant recipient who receives transplant at King Chulalongkorn Memorial Hospital.
  • Age >=18 years
  • Both deceased donor and living donor kidney transplantation will be included

Exclusion criteria

  • multiorgan transplantation
  • Known allergy to RLS or NSS

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

159 participants in 2 patient groups

Ringer lactate arm
Experimental group
Description:
The patient will receive RLS as a replacement fluid for urine output (mL per mL) until the patient have sufficient oral intake and fluid can be removed.
Treatment:
Drug: Ringer's Lactate Crystalloid Solutions
Normal saline arm with dextrose water
Active Comparator group
Description:
The patient will receive NSS with D5W as a replacement fluid for urine output (mL per mL) until the patient have sufficient oral intake and fluid can be removed.
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Central trial contact

Suwasin Udomkarnjananun, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems